Phase 3 Clinical Trial Demonstrates Combined Metabolic Activators (CMAs) Accelerates Recovery in Mild-to-Moderate COVID-19

Results of a phase 3, double-blind, placebo-controlled trial assessing whether a mixture of Combined Metabolic Activators (CMAs) targeted at mitochondrial function, could improve metabolic function...

New Phase 2 Clinical in COVID-19 Patients Finds Hydroxychloroquine (HCQ) Plus Nutritional Protocol Including Nicotinamide Riboside Significantly Improved Recovery Time Vs. HCQ Alone

On the heels of two previously published preclinical studies investigating the effect of viral infection on NAD+ levels, new clinical research in 93 mild-to-moderate COVID-19 infected patients is n...

Inflammation: A Double Edge Sword in Immunity

The latest research suggests NAD+ may play a central role in regulating inflammation for an effective—but targeted—immune response to dangerous pathogens such as the Coronavirus.

What is the Link Between NAD+ and Your Cells’ Innate Immune Response?

Just like our planet is mustering up the resources to fight the ongoing COVID-19 (Coronavirus) pandemic, so too do our cells need energy to support cellular repair. NAD+ may hold the key to support...

Raising NAD+ Levels With Niagen® (Nicotinamide Riboside) Inhibits Coronavirus Replication in Preclinical Cell Model

New preclinical research shared on scientific publishing website bioRxiv.org has demonstrated that increasing NAD+ levels can boost the activity of protective enzymes called PARPs and reduce corona...

Innate Immunity: The Body’s Security Force

Innate immunity is the body’s first line of defense against infection which is why this powerful security system needs all the fuel it can get. One cellular energy carrier critical to this process ...